Jean Luc Poyet0000-0002-3747-255X
Jean Luc Poyet received his Engineering degree in industrial microbiology in 1992 and the completed his Ph.D. degree in biochemistry with the study of plants antiviral proteins at the University of Franche-Comté, France, in 1996. He went on to complete his postdoctoral fellowship at Tomas Jefferson University (Philadelphia, USA), where he discovered and studied several adaptor proteins involved in the regulation of the apoptosis and inflammatory responses. In 2003, Dr. Poyet joined the French National Institute of Health and Medical Research (Inserm), where he currently holds a Research Director position. His team, in the context of its partnership with the pharmaceutical companies Servier Research Group (France) and Hybrigenics (Paris, France), is specialized in the identification of novel cancer therapeutic targets through systematic study of the apoptotic and inflammatory pathways. Poyet is also a Founding Member of CDithem (http://www.cdithem.fr), a consortium that aims at discovering inhibitors or stabilizers of macromolecular interactions with a drug discovery or chemical biology perspective.
Biography Updated on 17 January 2012